For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a curative treatment option rather than removing it, according to a new clinical guideline from the American Society for Radiation Oncology (ASTRO). The recommendations support trimodal therapy as an alternative to bladder removal and provide guidance on the use of radiation therapy after surgery and for patients with metastatic or symptomatic disease. The guideline, ASTRO's first to focus specifically on radiation therapy across bladder cancer care, was published in Practical Radiation Oncology, ASTRO's clinical practice journal.
ASTRO Releases Guideline Advocating Bladder Preservation in Bladder Cancer Treatment
The American Society for Radiation Oncology (ASTRO) has released a new clinical guideline advocating for bladder preservation as a curative treatment option for muscle-invasive bladder cancer, emphasizing trimodal therapy over bladder removal. This guideline, ASTRO's first focused on radiation therapy for bladder cancer, provides important recommendations for post-surgery treatment and management of metastatic disease. This development may influence cancer treatment protocols in Iran, particularly in improving patient outcomes.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%